The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity

Title
The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity
Authors
Keywords
podoplanin, PDPN, metastasis, monoclonal antibody, ADCC/CDC
Journal
Oncotarget
Volume 6, Issue 34, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-30
DOI
10.18632/oncotarget.5339

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started